Cargando…

Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial

Background: We evaluated the outcome of PCI of de novo stenosis with drug-coated balloons (DCB) versus drug-eluting stents (DES) in patients with insulin-treated diabetes mellitus (ITDM) versus non-insulin-treated diabetes mellitus (NITDM). Methods: Patients were randomized in the BASKET-SMALL 2 tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seeger, Julia, Wöhrle, Jochen, Scheller, Bruno, Farah, Ahmed, Ohlow, Marc-Alexander, Mangner, Norman, Möbius-Winkler, Sven, Weilenmann, Daniel, Stachel, Georg, Leibundgut, Gregor, Rickenbacher, Peter, Cattaneo, Marco, Gilgen, Nicole, Kaiser, Christoph, Jeger, Raban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057565/ https://www.ncbi.nlm.nih.gov/pubmed/36975883 http://dx.doi.org/10.3390/jcdd10030119

Ejemplares similares

Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial
por: Mahfoud, Felix, et al.
Publicado: (2022)

Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial
por: Farah, Ahmed, et al.
Publicado: (2022)

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2
por: Gilgen, Nicole, et al.
Publicado: (2018)

First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
por: Jeger, Raban, et al.
Publicado: (2016)

Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
por: Bjerking, Louise Hougesen, et al.
Publicado: (2019)

Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial
por: Fahrni, Gregor, et al.
Publicado: (2020)

Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique
por: Reichart, Christine, et al.
Publicado: (2019)

Drug-coated Balloons for Small Coronary Disease—A Literature Review
por: Arslani, Ketina, et al.
Publicado: (2021)

Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
por: Nestelberger, Thomas, et al.
Publicado: (2019)

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
por: Jeger, Raban V., et al.
Publicado: (2019)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
por: Singh, Gurpreet, et al.
Publicado: (2019)

Coronary artery perforation successfully treated with a second drug-eluting stent
por: Strycek, Matej, et al.
Publicado: (2023)

Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
por: Hansen, Kim Wadt, et al.
Publicado: (2019)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey
por: Wagener, Max, et al.
Publicado: (2022)

Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center
por: Shammas, Nicolas W, et al.
Publicado: (2014)

Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
por: Shammas, Nicolas W., et al.
Publicado: (2013)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
por: van der Heijden, Liefke C., et al.
Publicado: (2018)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Drug-eluting coronary stents – focus on improved patient outcomes
por: Jaffery, Zehra, et al.
Publicado: (2011)

Honeycomb-like structure in the right coronary artery treated with a drug-eluting stent: a case report and literature review
por: Lin, Maohuan, et al.
Publicado: (2018)

Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention
por: Schmucker, Johannes, et al.
Publicado: (2021)

Coronary pseudoaneurysm 1 week after complex percutaneous coronary intervention with drug‐eluting stent
por: Namazi, Mohammad Hasan, et al.
Publicado: (2020)

Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula
por: Gupta, Ankush, et al.
Publicado: (2020)

Percutaneous coronary intervention in insulin‐treated diabetic patients: A meta‐analysis
por: Ge, Ying, et al.
Publicado: (2022)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Coronary Aneurysm Occurring Late after Drug-Eluting Stent Implantation
por: Abergel, Etan, et al.
Publicado: (2011)

Novel drug-eluting stents in the treatment of de novo coronary lesions
por: Capodanno, Davide, et al.
Publicado: (2011)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Extended Outcomes of Complex Coronary Disease in the Drug Eluting Stent Era
por: Desrosiers, Kevin P., et al.
Publicado: (2011)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

The comparative short-term efficacy and safety of drug-coated balloon vs. drug-eluting stent for treating small-vessel coronary artery lesions in diabetic patients
por: Li, Kui, et al.
Publicado: (2022)

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
por: Jiang, Zhi-Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sr9pnf85uapfjppqst8d2l3rl9